Entity

Alzheimer's disease

progressive, neurodegenerative disease characterized by memory loss

Express your sentiment! Sign in!
Entity sentiment
1
North Shore author releases book to help kids understand Alzheimer"s
Massachusetts Alzheimer's disease
Science
Francisco Lopera"s Journey in the Andes to Unravel Alzheimer’s Mystery
Andes Alzheimer's disease
New research reveals parental influence on Alzheimer’s inheritance risk
Alzheimer's disease
Study links light pollution to Alzheimer’s risk in younger adults
Alzheimer's disease
Biogen/Eisai's Leqembi Brings Hope To Early Alzheimer's Patients Amid Logistical Challenges - Biogen (NASDAQ:BIIB)
Alzheimer's disease
Study links nose picking to increased Alzheimer’s risk
Alzheimer's disease
Kinsome app launched to connect kids and grandparents amid Alzheimer"s challenge
Alzheimer's disease
Microglia malfunction: how brain immune cells may drive dementia
Alzheimer's disease
SNP health secretary caught buying Oasis tickets during Alzheimer"s meeting
Neil Gray Alzheimer's disease
Society
Managing Mental Health While Caring for a Loved One with Alzheimer’s
Alzheimer's disease
NICE Rejects Alzheimer’s Drug Leqembi in the U.K
United Kingdom Alzheimer's disease
Science
Experimental drug boosts memory in Alzheimer’s mice study
Alzheimer's disease
NHS Rejects Funding for Controversial Alzheimer’s Drug in 2023
Alzheimer's disease
Alzheimer’s Drug Rejected: What This Means for Patients
Alzheimer's disease
Dementia Communication Tips: 16 Safe Phrases to Use
Alzheimer's disease
Larry Dean’s Standup Show: Humor and Heart in Scotland
Alzheimer's disease
LONDON — Britain’s drug regulator has approved Leqembi, an Alzheimer’s treatment, marking it as the first medication to demonstrate some ability to slow the progression of the disease. However, the U.K. government is unlikely to fund the drug after the National Institute for Health and Care Excellence (NICE) issued draft guidance stating that the benefits do not justify the costs to taxpayers. The treatment requires bi-weekly hospital visits for administration and monitoring, raising concerns about its overall value
Alzheimer's disease
Title: Calls for Legal Action Against Scientific Fraud Following Heart Surgery Guidelines Scandal
Francesca Gino Alzheimer's disease
High Microplastic Levels in Human Brains Linked to Alzheimer's
Alzheimer's disease
Alzheimer's Drug Lecanemab Too Costly for NHS
Nice Alzheimer's disease
New Research Offers Hope for Alzheimer's Treatment by Targeting Brain Cells
Alzheimer's disease
Society
Child killed by elderly driver in Edinburgh
Edinburgh Alzheimer's disease
New Study Finds 2 Surprising Risk Factors for Dementia
dementia Alzheimer's disease
Location Impact on Alzheimer's Diagnosis
Alzheimer's disease
Tsimane Tribe: A Study in Longevity and Health in the Bolivian Jungle
Alzheimer's disease
High Blood Pressure Linked to Alzheimer's Risk
Alzheimer's disease
High Blood Pressure Linked to Higher Alzheimer's Risk
Alzheimer's disease
Society
Elderly Woman Rescued from Tampa Swamp
Tampa Alzheimer's disease
Concerns Arise Over New Alzheimer's Treatments
Alzheimer's disease
Loneliness and Alzheimer's Update
Alzheimer's disease
Body Fat Linked to Alzheimer’s and Parkinson’s Risk
Alzheimer's disease
Ozempic: A Potential Breakthrough for Alzheimer's Treatment
Alzheimer's disease